Gaining a deeper understanding of SLC7A11’s dual role in these cell death processes could lead to innovative strategies for influencing cell fate in various diseases, particularly in the cancer treatment, where the ability to evade cell death is a key feature of tumor progression. The gene discussed is SLC7A11; the disease is neoplasm.